---
title: 'Metal chelators and neurotoxicity: lead, mercury, and arsenic'
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-9CI68TFZ" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Bjørklund, G., Mutter, J., &#38; Aaseth, J. (2017). Metal chelators and neurotoxicity: lead, mercury, and arsenic. <i>Archives of Toxicology</i>, 1–11. <a href="https://doi.org/10.1007/s00204-017-2100-0">https://doi.org/10.1007/s00204-017-2100-0</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-9CI68TFZ" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1516562" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/9CI68TFZ" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-9CI68TFZ" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-9CI68TFZ" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-9CI68TFZ" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://doi.org/10.1007/s00204-017-2100-0" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://doi.org/10.1007/s00204-017-2100-0" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-9CI68TFZ"></div>
</article>
<div id="csl-bib-meta-9CI68TFZ" class="csl-bib-meta">
  <article id="about-article-9CI68TFZ" class="about_pub-article">
    <h1>Om</h1>
    Bjørklund et al. har gjennomgått bruken av visse kjemikaliar, kalla metallkjelatorar, for å behandle forgiftning frå bly, kvikksølv og arsen. Dei fann at DMSA, ein type kjelator, er tryggare og mindre giftig enn eldre behandlingar som BAL og DMPS. For moderat blyforgiftning er DMSA anbefalt over CaEDTA på grunn av færre biverknader. I alvorlege tilfelle kan kombinasjonen av DMSA med eit anna stoff, Monensin, bidra til å fjerne bly frå kroppen meir effektivt. DMSA og DMPS er også lovande for kvikksølvforgiftning, medan DMPS er betre for arsenforgiftning. Forfattarane foreslår at kombinasjonen av låge dosar av BAL med DMPS kan forbetre behandlinga ved å hjelpe kroppen med å utskille desse metalla raskare. Denne forskinga er viktig for å forbetre behandlingar for tungmetallforgiftning.
  </article>
  <article id="keywords-article-9CI68TFZ" class="keywords-article">
    <h1>Emneord</h1>
    Metallkjelatorar, Nevrotoksisitet, Blyforgiftning, Kvikksølvforgiftning, Arsenforgiftning, Antidotterapi
  </article>
  <article id="abstract-article-9CI68TFZ" class="abstract-article">
    <h1>Samandrag</h1>
    This article reviews the clinical use of the 
metal chelators sodium 2,3-dimercapto-1-propanesulfonate 
(DMPS), meso-2,3-dimercaptosuccinic acid (DMSA), 
and calcium disodium edetate (CaEDTA, calcium EDTA) 
in overexposure and poisonings with salts of lead (Pb), 
mercury (Hg), and arsenic (As). DMSA has considerably 
lower toxicity than the classic heavy metal antagonist BAL 
(2,3-dimercaptopropanol) and is also less toxic than DMPS. 
Because of its adverse efects, CaEDTA should be replaced 
by DMSA as the antidote of choice in treating moderate Pb 
poisoning. Combination therapy with BAL and CaEDTA 
was previously recommended in cases of severe acute Pb 
poisoning with encephalopathy. We suggest that BAL in 
such cases acted as a shuttling Pb transporter from the intrato 
the extracellular space. The present paper discusses if a 
combination of the extracellularly distributed DMSA with 
the ionophore, Monensin may provide a less toxic combination 
for Pb mobilization by increasing both the efux of 
intracellularly deposited Pb and the urinary Pb excretion. 
Anyhow, oral therapy with DMSA should be continued with 
several intermittent courses. DMPS and DMSA are also 
promising antidotes in Hg poisoning, whereas DMPS seems 
to be a more efcient agent against As poisoning. However, 
new insight indicates that a combination of low-dosed BAL  
plus DMPS could be a preferred antidotal therapy to obtain 
mobilization of the intracerebral deposits into the circulation for subsequent rapid urinary excretion.
  </article>
  <article id="sdg-article-9CI68TFZ" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="/nn/archive/?key=?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-9CI68TFZ" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li>
        <a href="/nn/archive/?key=3DCRN523">Universitetet i Innlandet</a>
      </li>
      <li>
        <a href="/nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=QV2QKSDS">2017</a>
      </li>
      <li>
        <a href="/nn/archive/?key=76Z26YNP">November</a>
      </li>
    </ul>
  </article>
</div>
